LMBS vs. HELX
LMBS (First Trust Low Duration Mortgage Opportunities ETF) and HELX (Franklin Genomic Advancements ETF) are both exchange-traded funds - LMBS is a Mortgage Backed Securities fund actively managed by First Trust, while HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton. Both are actively managed. Over the past 5 years, LMBS returned 3.03%/yr vs -4.52%/yr for HELX. At a 0.16 correlation, their price movements are largely independent. LMBS charges 0.68%/yr vs 0.50%/yr for HELX.
Performance
LMBS vs. HELX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LMBS achieves a 1.24% return, which is significantly higher than HELX's -4.52% return.
LMBS
- 1D
- -0.10%
- 1M
- 0.11%
- YTD
- 1.24%
- 6M
- 1.47%
- 1Y
- 6.09%
- 3Y*
- 5.73%
- 5Y*
- 3.03%
- 10Y*
- 2.67%
HELX
- 1D
- 1.03%
- 1M
- 2.06%
- YTD
- -4.52%
- 6M
- -7.35%
- 1Y
- 31.28%
- 3Y*
- 4.70%
- 5Y*
- -4.52%
- 10Y*
- —
LMBS vs. HELX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
LMBS First Trust Low Duration Mortgage Opportunities ETF | 1.24% | 7.05% | 5.15% | 6.10% | -3.07% | -0.91% | 0.28% |
HELX Franklin Genomic Advancements ETF | -4.52% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
Correlation
The correlation between LMBS and HELX is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.16 |
The correlation between LMBS and HELX shifts across timeframes, from 0.16 (all time) to 0.32 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LMBS vs. HELX — Risk / Return Rank
LMBS
HELX
LMBS vs. HELX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Low Duration Mortgage Opportunities ETF (LMBS) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LMBS | HELX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.59 | ||
| Sortino ratioReturn per unit of downside risk | +2.62 | ||
| Omega ratioGain probability vs. loss probability | 1.62 | 1.26 | +0.36 |
| Calmar ratioReturn relative to maximum drawdown | 4.28 | 1.74 | +2.53 |
| Martin ratioReturn relative to average drawdown | 18.25 | 4.52 | +13.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LMBS | HELX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.10 | 1.51 | +1.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.19 | -0.19 | +1.38 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 1.14 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.13 | 0.23 | +0.90 |
Drawdowns
LMBS vs. HELX - Drawdown Comparison
The maximum LMBS drawdown since its inception was -6.49%, smaller than the maximum HELX drawdown of -58.75%. Use the drawdown chart below to compare losses from any high point for LMBS and HELX.
Loading charts...
Drawdown Indicators
| LMBS | HELX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -6.49% | -58.75% | +52.26% |
Max Drawdown (1Y)Largest decline over 1 year | -1.43% | -18.01% | +16.58% |
Max Drawdown (3Y)Largest decline over 3 years | -1.72% | -29.48% | +27.76% |
Max Drawdown (5Y)Largest decline over 5 years | -6.12% | -58.75% | +52.63% |
Max Drawdown (10Y)Largest decline over 10 years | -6.49% | — | — |
Current DrawdownCurrent decline from peak | -0.34% | -40.09% | +39.75% |
Average DrawdownAverage peak-to-trough decline | -0.80% | -34.32% | +33.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.33% | 6.94% | -6.61% |
Volatility
LMBS vs. HELX - Volatility Comparison
The current volatility for First Trust Low Duration Mortgage Opportunities ETF (LMBS) is 0.68%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 6.88%. This indicates that LMBS experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LMBS | HELX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.68% | 6.88% | -6.20% |
Volatility (6M)Calculated over the trailing 6-month period | 1.45% | 16.18% | -14.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 1.97% | 20.88% | -18.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 2.56% | 24.13% | -21.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 2.36% | 27.39% | -25.03% |
LMBS vs. HELX - Expense Ratio Comparison
LMBS has a 0.68% expense ratio, which is higher than HELX's 0.50% expense ratio.
Dividends
LMBS vs. HELX - Dividend Comparison
LMBS's dividend yield for the trailing twelve months is around 4.10%, more than HELX's 0.41% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 0.41% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LMBS First Trust Low Duration Mortgage Opportunities ETF | 4.10% | 4.08% | 4.28% | 3.96% | 2.22% | 2.04% | 2.27% | 2.55% | 2.76% | 2.73% | 2.84% | 3.03% |
Frequently Asked Questions
LMBS and HELX have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (6.88%) compared to LMBS (0.68%). In terms of maximum drawdown, LMBS dropped -6.49% vs HELX's -58.75%.
On 5-year performance, LMBS leads with 3.03% vs -4.52% for HELX. On fees, HELX is cheaper at 0.50% per year. On volatility, LMBS has been the lower-risk option at 0.68%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, LMBS has performed better with a 3.03% return vs -4.52%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HELX is cheaper with a 0.50% expense ratio, compared with 0.68% for LMBS.
LMBS has the higher dividend yield at 4.10%, compared with 0.41% for HELX.
LMBS is categorized as Mortgage Backed Securities, while HELX is Health & Biotech Equities. They also come from different issuers: First Trust and Franklin Templeton. Their fees differ too: 0.68% for LMBS and 0.50% for HELX.
LMBS currently has the higher Sharpe Ratio (3.10 vs 1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LMBS and HELX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer